Your Directors have pleasure in presenting their 23rd Annual Report on the business and operations of the
Company and the accounts for the Financial Year ended March 31,2025.

1. Financial Summary or Highlights:

2. State of Company’s Affair:

The revenue for the year has been increased to Rs. 17,300.37 lakhs as compared to Rs. 14,267.89 lakhs in
the previous year at the same time expenditure also increased to Rs. 15,974.80 lakhs as compared to Rs.
12,586.26 lakhs in the previous year. The company has earned net profit of Rs. 1,170.82 lakhs in the current
year as compared to the profit of Rs. 1,424.23 lakhs in the previous year which resulted in decrease in EPS
from Rs. 5.73 to Rs. 4.71.

3. Investment in Shrutina Nexgen Solar LLP:

The Company (holding 18%) along with its Promoter Group Entities viz. Shrutina Nexgen LLP (holding 74%) as
its Designated Partners and Rajoo Engineers Limited (holding 7%) and Rajoo Innovation Centre LLP (holding
1%) as its Partners formed a Limited Liability Partnership namely, Shrutina Nexgen Solar LLP to reduce its
carbon footprint and improve energy efficiency. By investing in solar power generation, the company aligns
itself with ESG goals and government clean energy mandates. This strategy ensures long-term energy cost
savings and reflects a proactive commitment to environmental stewardship. Sustainability also boosts
brand value among environmentally-conscious clients and investors.

4. Bonus Issue:

Pursuant to recommendation of Board of Directors at its meeting held on October 28, 2024 and approval of
shareholders by way of postal ballot vide resolution dated November 28, 2024, the Company has on
December 16, 2024 allotted 41,39,840 equity shares of Rs. 10 each in the ratio of 1:5 i.e. one new equity

bonus share of Rs. 10 each for every five existing fully paid equity shares of Rs. 10 each, to the existing
shareholders of the Company holding shares at the close of business hours on the Record Date i.e.
December 13, 2024. Post Bonus Issue, issued and paid-up equity capital of the Company was increased
from Rs. 2,069.92 lakhs to Rs. 2,483.90 lakhs.

5 .Utilisation of proceeds of Initial Public Offer of Equity Shares:

During the FY 2022-23, the Company floated Initial Public Offer ("IPO") of its Equity Shares. The Company, for
every quarter, has submitted the Statement of Deviation or Variation as required under Regulation 32 of the
Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015
("SEBI Listing Regulations") to National Stock Exchange of India Limited ("NSE"), where the equity shares of the
Company are listed.

Details of utilisation of IPO proceeds are given below:

There are no unutilized proceeds as on the March 31,2025. There has been no deviation or variation in the
utilisation of the IPO proceeds of the Company.

6. Dividend:

The Board of the Company, in its meeting held on May 05, 2025, has recommended a final dividend of Re. 1
per equity share of the face value of Rs. 10 each fully paid up for the financial year ended March 31,2025,
subject to the approval of the Shareholders at the Annual General Meeting (AGM).

Final Dividend on equity shares for FY 2024-25, if approved, would result in a cash outflow of approximately
Rs. 248.39 lakhs.

In view of the changes made under the Income-Tax Act, 1961, by the Finance Act, 2020, dividends paid or
distributed by the Company shall be taxable in the hands of the Shareholders. The Company shall,
accordingly, make the payment of the Final Dividend after deduction of tax at source. For more clarity on
deduction of tax, please refer para on Note No. 10 in the notes to the Notice of 23rd AGM.

7. Transfer to Reserves:

During the year under review, the Company has not made transfer to any Reserves.

8. Web Address of Annual Return :

The Annual Return of the Company as on March 31,2024 in Form MGT-7 is available on the website of the
Company at www.essenspeciality.com/investorszone.html and the Annual Return of the Company as on
March 31, 2025 will be made available on the website of the Company at
www.essenspeciality.com/investorszone.html once it is filed with the MCA.

The Company has an appropriate mix of Executive Directors, Non-Executive Directors and Independent
Directors in compliance with the applicable provisions of the Companies Act, 2013 and SEBI Listing
Regulations. The Board of the Company consists of eminent individuals of diverse backgrounds with skills,
experience and expertise in various areas as detailed in the Corporate Governance Report forming part of
the Annual Report.

During the year under review following changes occurred in Board of Directors and Key Managerial
Personnel of the Company:

• Pursuant to recommendation of Nomination and Remuneration Committee and Board of Directors, Mr.
Utkarsh Rajeshbhai Doshi (DIN: 07234144) was appointed as an Executive Director of the Company by
shareholders through postal ballot with effect from November 28, 2024.

• Pursuant to recommendation of Nomination and Remuneration Committee, Mr. Clayton Roy Thompson
(DIN: 10850043) was appointed as an Additional Director (Non-Executive & Independent) by Board of
Directors in their meeting held on November 29, 2024. Further, he was appointed as a Non-Executive
Independent Director by shareholders through postal ballot dated February 27, 2025.

Directors and KMPs as on March 31,2025 are as under:

In accordance with provisions of the Companies Act, 2013, Ms. Karishma Rajesh Doshi (DIN: 08748863),
Executive Director of the Company retires by rotation at the ensuing AGM and being eligible, offers herself for
re-appointment.

10. Declaration from Independent Directors

The Company has received declaration from all the Independent Directors of the Company confirming that
they meet with the criteria of independence as prescribed under sub-section (6) of Section 149 of the
Companies Act, 2013 read with rule 6 of the Companies (Appointment and Qualification of Director) Rules,
2014 and Regulation 16 of SEBI Listing Regulations.

In the opinion of the Board, all the Independent Directors possess the integrity, expertise and experience
including the proficiency required to be Independent Directors of the Company, fulfil the conditions of

independence as specified in the Act and the SEBI Listing Regulations and are independent of the
management and have also complied with the Code for Independent Directors as prescribed in Schedule
IV of the Companies Act, 2013.

11. Board Evaluation:

The Nomination and Remuneration Committee ("NRC") has formulated a Policy and laid down the criteria
for evaluation of the Board and its Committees and the same has been adopted by the Board. Their
performance of the Board and its Committees were evaluated after seeking inputs from all the Directors on
the basis of criteria such as the composition and meetings, role & responsibilities and overall effectiveness of
the Board & Committees. Evaluation of the performance of all Individual Directors (including Independent
Directors and Chairperson) was also done this year. The details of the Board Evaluation process are
mentioned in the Corporate Governance Report forming part of the Annual Report.

12. Board Meetings:

The meeting of the Board of Directors was duly convened and held 9 (Nine) times during the year under
review. The details of the meetings and the attendance of the Directors are mentioned in the Corporate
Governance Report forming part of the Annual Report.

13. Management Discussion and Analysis:

In terms of Regulation 34(2)(e) of SEBI Listing Regulations, a detailed report on Management Discussion and
Analysis (MDA) Report is included in this Report as Annexure-I.

14. Business Responsibility and Sustainability Report:

In accordance with provisions of Regulation 34(2)(f) of SEBI Listing Regulations the Company being SME
listed, requirement of Business Responsibility and Sustainability Report is not applicable to the Company.

15. Directors’ Responsibility Statement:

Pursuant to Section 134 (5) of the Companies Act, 2013, it is hereby confirmed that:

a) in the preparation of the annual accounts, the applicable accounting standards have been followed
along with proper explanation relating to material departures, if any;

b) the directors have selected such accounting policies and applied them consistently and made
judgments and estimates that are reasonable and prudent so as to give a true and fair view of the state
of affairs of the company at the end of the financial year and of the profit of the company for the year
under review;

c) the directors have taken proper and sufficient care for the maintenance of adequate accounting
records in accordance with the provisions of the Companies Act, 2013 for safeguarding the assets of the
company and for preventing and detecting fraud and other irregularities;

d) the directors have prepared the annual accounts on a going concern basis;

e) the directors have laid down internal financial controls to be followed by the company and that such
internal financial controls are adequate and are operating effectively; and

f) the directors have devised proper systems to ensure compliance with the provisions of all applicable
laws and that such systems are adequate and operating effectively.

a. Statutory Auditors

Pursuant to the provisions of section 139 of the Companies Act, 2013 and the Rules framed there under,
M/s. Rushabh R. Shah and Co., Chartered Accountants (Membership No.: 607585, FRN: 156419W), were
appointed as statutory auditors of the Company for a period of five years at the 20th AGM held on 30th
September, 2022 until the conclusion of the 25th AGM. Rushabh Shah has confirmed his eligibility to
remain continue as the auditor of the Company for his remaining term.

Report given by M/s. Rushabh R. Shah and Co., Chartered Accountants on Financial Statements of the
Company for FY 2024-25 are part of the Annual Report. The Notes on financial statement referred to in the
Auditors' Report are self-explanatory and therefore, do not call for any further explanation or comments
from the Board.

b. Cost Auditors

The Company made and maintained cost account and records as specified by the Central
Government under Section 148(1) of the Companies Act, 2013. For the financial year 2024-25, M/s.
Sagar M. Kapadiya & Co., Cost Accountants (FRN: 103615) having Mr. Sagar M. Kapadiya (Membership
No: 36767) have conducted the audit of the cost records of the Company.

Further, the Board of Directors, on the recommendation of Audit Committee, re-appointed M/s. Sagar M.
Kapadiya & Co., to conduct the audit of the cost records of the Company for the financial year 2025-26.

The remuneration payable to the Cost Auditor is subject to ratification by the Members at ensuing
General Meeting. Accordingly, remuneration payable to M/s. Sagar M. Kapadiya & Co. proposed to be
ratified by members in 23rd AGM.

c. Secretarial Auditors

Pursuant to the provisions of section 204 of the Companies Act, 2013 read with Rule 9 of the Companies
(Appointment and Remuneration of Managerial Personnel) Rules, 2014 and Regulation 24A of the SEBI
Listing Regulations, Board of Directors, on the recommendation of the Audit Committee, had appointed
CS Nirav D. Vekariya, Practising Company Secretary (CP No. 17709 and Peer Review No. 2442/2022) as
Secretarial Auditor of the Company for the financial year ended March 31,2025.

The Secretarial Audit Report for the FY 2024-25 is included in this Report as Annexure-II. There has been no
qualification, reservation or adverse remark or disclaimer in their Report.

In accordance with the recent amendments to the SEBI Listing Regulations, the Board has
recommended to the members for their approval, appointment of CS Nirav D. Vekariya, Practising
Company Secretary (CP No. 17709 and Peer Review No. 2442/2022) as the Secretarial Auditor of the
Company, for a term of 5 (five) consecutive financial years commencing from the financial year 2025¬
26 to the financial year 2029-30.

d. Internal Auditors

Pursuant to the provisions of section 138 of the Companies Act, 2013 and the Rules framed there under,
Board of Directors, on the recommendation of the Audit Committee, have appointed M/s. Savjani &

Associates, Chartered Accountants (FRN: 133389W) as Internal Auditors of the Company for the financial
year 2024-25.

17. Reporting of Fraud:

During the year under review, the Statutory Auditors and Cost Auditors have not reported any instances of
frauds committed in the Company by its Officers or Employees, to the Audit Committee or the Board of
Directors under Section 143(12) of the Act, details of which needs to be mentioned in Director's Report.

18. Particulars of Loans, Guarantees or Investments:

Details of Investments made by the Company during the year under review are described in Note No. 11 of
Annual Financial Statements attached to Annual Report. Further, the Company has not given any loan or
provided any guarantee or security in favour of other parties under Section 186 of Companies Act, 2013.

19. Particulars of Contracts or Arrangements with Related Parties:

All contracts/ arrangements/ transactions entered by the Company during the financial year with related
parties were in the ordinary course of business and on an arm's length basis. There were no material related
party transactions entered, during the year under review, which require disclosure in Form AOC-2.

20. Deposits:

During the year under review, the Company has not accepted any deposits under Chapter V of the Act and,
as such no amount on account of principal or interest on deposit were outstanding as of the Balance Sheet
date.

21. Conservation of Energy, Technology Absorption and Foreign Exchange Earnings and Outgo:

The details of conservation of energy, technology absorption, foreign exchange earnings and outgo are as
follows :

A) Conservation of Energy:

i. The steps taken or impact on conservation of energy: The Company has continued its efforts to
improve energy efficiency with more vigour and depth. The Company continually took necessary
steps to absorb and adopt the latest technologies and innovations in the Plastic Processing for
Manufacturing home decor products. All machinery and equipment are continuously serviced,
updated and overhauled in order to maintain them in good condition. This resulted in lesser energy
consumption. Energy audits and Inter unit studies are carried out on a regular basis for taking steps for
reduction of the energy consumption.

ii. The steps taken by the Company for utilizing alternate sources of energy:

a. The company has installed and commissioned 275.20 KW (DC) capacity Solar Power Plant in the
state of Gujarat at Village HADAMTALA, Taluka Kotda-Sangani, District Rajkot.

b. All efforts are made to use more natural lights in offices/Factory/stores premises to optimize the
consumption of energy.

c. the Company along with group entities of the Company has formed a Limited Liability Partnership
"SHRUTINA NEXGEN SOLAR LLP (LLPIN: ACH-3671)", which is registered with Registrar of Companies,
Gujarat on May 26, 2024. Shrutina Nexgen Solar LLP is formed by Essen Speciality Films Limited

Limited (holding 18%) along with Promoter Group Entities viz. Shrutina Nexgen LLP (holding 74%),
Rajoo Engineers Limited (holding 7%) and Rajoo Innovation Centre LLP (holding 1%) as its Partners.
The LLP is incorporated for business purpose: To carry on the business of generating,
accumulating, distributing and supplying Solar Energy for its own use or for sale to Governments,
State Electricity Boards, Intermediaries in Power Transmission/ Distribution, Companies, Industrial
Units, or to other types of users/ consumers of Energy.

iii. The capital investment on energy conservation equipment: Nil

B) Technology Absorption:

i. The efforts made towards technology absorption: The Company continues to adopt and use the
latest technologies to improve the productivity and quality of its products.

ii. The benefits derived like product improvement, cost reduction, product development or import
substitution: Due to integrated facility and infusion of new technology, the Company is in position to
offer most energy efficient products to consumers.

iii. In case of imported technology (imported during the last three years reckoned from the beginning of
the financial year): No technology was imported during last four years

iv. The expenditure incurred on Research and Development: Nil

C) Foreign Exchange Earnings and Outgo:

For Earnings and Expenditure in Foreign Currencies, please refer to Note 32 & 33 of Notes forming part of
the Financial Statements attached with the Annual Report.

22. Nomination and Remuneration Policy:

For the purpose of selection of any Director, the Nomination & Remuneration Committee identifies persons
of integrity who possess relevant expertise, experience and leadership qualities required for the position. The
Committee also ensures that the incumbent fulfils such other criteria with regard to age and other
qualifications as laid down under the Companies Act, 2013 or other applicable laws.

The Board has framed a policy for selection, appointment/ reappointment and remuneration of
Directors & Senior Management, which is available at

https://www.essenspeciality.com/pdf/Policies/Nomination_and_Remuneration_Policy.pdf.

23. Risk Management Policy:

The Company has adopted a Risk Management Policy which is available at
https://www.essenspeciality.com/pdf/Policies/Risk_Management_Policy.pdf.

Directors are taking appropriate steps to manage various identified and unidentified potential risks affecting
assets and business activities of the company. Considering the present assets positions and business volume
Directors are of the opinion that the same is adequate for the Company. More details on risk management
are furnished in the MDA Report forming part of this Report. There are no risks which in the opinion of the Board
threaten the existence of the Company.

24. Corporate Social Responsibility:

The Company has constituted a Corporate Social Responsibility (CSR) Committee in accordance with
Section 135 of the Act, comprising of three Directors including Independent Directors. The composition and
report on CSR is attached herewith as Annexure -Ill.

25. Vigil Mechanism/ Whistle Blower Policy:

Pursuant to the provisions of Section 177 of the Act and Regulation 22 of SEBI Listing Regulations, the
Company has established a Vigil Mechanism/ Whistle Blower Policy for Directors, employees, vendors,
customers and other stakeholders of the Company to raise and report concerns regarding any unethical
conduct, irregularity, misconduct, actual or suspected fraud or any other violation of the Policy within the
Company. The vigil mechanism provides for adequate safeguards against victimisation of persons who use
such mechanism and for direct access to the chairperson of the Audit Committee in appropriate or
exceptional cases. The Whistle Blower Policy can be accessed on the Website of the Company at
https://www.essenspeciality.com/pdf/Policies/Whistle_Blower_Policy.pdf.

26. Details of Subsidiary, Joint Venture or an Associate Companies:

During the year under review, no Company became or ceased to be subsidiaries, joint ventures or
associates of the Company.

27. Internal Financial control & its adequacy:

Internal financial control systems of the Company are commensurate with its size and the nature of its
operations. These have been designed to provide reasonable assurance with regard to recording and
providing reliable financial and operational information, complying with applicable accounting standards
and relevant statutes, safeguarding assets from unauthorised use, executing transactions with proper
authorisation and ensuring compliance of corporate policies. The Company has a well-defined delegation
of authority with specified limits for approval of expenditure, both capital and revenue. Details of internal
control system are given in the MDA Report forming part of this Report.

28. Details of Remuneration of Directors and KMPs and Particulars of Employees:

Disclosure pertaining to remuneration and other details required under provisions of Section 197(12) of the
Act read with Rule 5(1) of the Companies (Appointment and Remuneration of Managerial Personnel) Rules,
2014, are attached herewith as Annexure - IV.

In terms of the provisions of Section 197(12) of the Act read with Rules 5(2) and 5(3) of the Companies
(Appointment and Remuneration of Managerial Personnel) Rules, 2014, during the financial year 2024-25
there were no employees drawing remuneration in excess of the limits set out in the said rules.

29. Changes in Nature of Business:

During the year under review, there were no changes in the nature of business of the Company.

30. Material Changes and Commitments:

There were no material changes during the year affecting the Financial Position of the Company other than
issuance of fresh shares as detailed in this report.

31. Details of Significant and Material Orders Passed by the Regulators, Courts and Tribunals:

No significant and material order has been passed by the regulators, courts, tribunals impacting the going
concern status and Company's operations in future.

32. Disclosures under Sexual Harassment of Women at Workplace (Prevention, Prohibition & Redressal) Act,
2013:

The Company has zero tolerance for sexual harassment at workplace and has adopted a policy on
prevention, prohibition and redressal of sexual harassment at workplace in line with the provisions of the
Sexual Harassment of Women at Workplace (Prevention, Prohibition and Redressal) Act, 2013 and the Rules
thereunder and same is posted on the website of the Company and can be accessed at
https://www.essenspeciality.com/pdf/Policies/Prevention_of_Sexual_Harressment_Policy.pdf.

The Company has constituted an Internal Complaints Committee ("ICC") in accordance with the Section 4
of the Sexual Harassment of Women at Workplace (Prevention, Prohibition and Redressal) Act, 2013. No
complaint pertaining to sexual harassment was received during FY 2024-25.

33. Details of Proceedings under the Insolvency and Bankruptcy Code, 2016:

There are no proceedings initiated/ pending against the Company under the Insolvency and Bankruptcy
Code, 2016 which materially impact the business of the Company.

34. Difference between Valuation on One Time Settlement and while availing Loan from Banks and
Financial Institution:

There were no instances where the Company required the valuation for one time settlement or while taking
the loan from the Banks or Financial institutions.

35. Disclosure about Secretarial Standard:

The Directors have devised proper systems to ensure compliance with the provisions of all applicable
Secretarial Standards and that such systems are adequate and operating effectively.

36. Appreciation:

The Directors express their appreciation to all employees of the various divisions for their diligence and
contribution to performance. The Directors also record their appreciation for the support and co-operation
received from franchisees, dealers, agents, suppliers, bankers and all other stakeholders. Last but not the
least, the Directors wish to thank all shareholders for their continued support.

For and on behalf of Board of Directors of
Essen Speciality Films Limited

Pallav K. Doshi

Chairman and Wholetime Director
DIN:02542047

Date : August 31,2025
Place : Veraval (Shapar)